Updates are available Correction dated 2023-06-23
Click to view Correction: https://doi.org/10.1038/s41467-023-39437-x
-
Authors
Zhao, Jianyuan
Wang, Jing
Pang, Xu
Liu, Zhenlong
Li, Quanjie
Yi, Dongrong
Zhang, Yongxin
Fang, Xiaomei
Zhang, Tao https://orcid.org/0000-0002-3870-4607
Zhou, Rui
Zhang, Tao
Guo, Zhe
Liu, Wancang https://orcid.org/0000-0003-1465-901X
Li, Xiaoyu
Liang, Chen
Deng, Tao
Guo, Fei
Yu, Liyan
Cen, Shan https://orcid.org/0000-0003-3358-0411
-
Funding
Funding for this research was provided by:
Chinese Academy of Medical Sciences (2021-I2M-1-038)
- License Information
-
More Information
Article History
Received: 8 October 2021
Accepted: 16 March 2022
First Online: 19 April 2022
Change Date: 23 June 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-023-39437-x
Competing interests
: S.C., L.Y., J.Z., Y.Z., T.Z., X.P. and X.F. are inventors of the related patent/application 201710077812.X., which was filed by the Institute of Medicinal Biotechnology. This patent includes some in vivo antiviral data described herein, which does not impose any restrictions for the scientific use of the related compounds. The remaining authors declare no competing interests.
